Cycling hypoxia and free radicals regulate angiogenesis and radiotherapy response
Open accessThe DOI matches its Crossref record; 162 of the 162 references it cites were found in a registry or an index.
Abstract
Hypoxia and free radicals, such as reactive oxygen and nitrogen species, can alter the function and/or activity of the transcription factor hypoxia-inducible factor 1 (HIF1). Interplay between free radicals, hypoxia and HIF1 activity is complex and can influence the earliest stages of tumour development. The hypoxic environment of tumours is heterogeneous, both spatially and temporally, and can change in response to cytotoxic therapy. Free radicals created by hypoxia, hypoxia-reoxygenation cycling and immune cell infiltration after cytotoxic therapy strongly influence HIF1 activity. HIF1 can then promote endothelial and tumour cell survival. As discussed here, a constant theme emerges: inhibition of HIF1 activity will have therapeutic benefit.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Many human cancers contain regions of hypoxia because of rapid cell proliferation and the presence of intratumoral blood vessels that are structurally and functionally abnormal, resulting in both spatial and temporal heterogeneity of blood flow (1, 2).”
From Digoxin and other cardiac glycosides inhibit HIF-1α synthesis and block tumor growth (2008) · cites this paper as [2]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“ROS production later stabilizes the HIF-1α protein and increases expression of HIF-1α and its target genes (Moeller et al., 2004;Dewhirst et al., 2008;Harada et al., 2009).”
From Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer (2016) · cites this paper as Dewhirst et al., 2008
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Kasuno, K., Takabuchi, S., Fukuda, K., Kizaka-Kondoh, S., Yodoi, J., Adachi, T., Semenza, G. L., & Hirota, K. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m308197200 · Cited by 226
RetractedPlum, F. (1960) · Archives of Neurology · doi:10.1001/archneur.1960.03840090124020 · Cited by 10,364
Tumor angiogenesis: therapeutic implications
Sherwood, L. M., Parris, E. E., & Folkman, J. (1971) · New England Journal of Medicine · doi:10.1056/nejm197111182852108 · Cited by 10,187
Targeting HIF-1 for cancer therapy
Semenza, G. L. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1187 · Cited by 6,717
Jaakkola, P., Mole, D. R., Tian, Y.-M., Wilson, M. I., Gielbert, J., Gaskell, S. J., Kriegsheim, A. V., Hebestreit, H. F., Mukherji, M., Schofield, C. J., et al. (2001) · Science · doi:10.1126/science.1059796 · Cited by 5,535 · cited 1×
“The HIF1α subunit is exquisitely regulated by hydroxylation of proline residues in its oxygen-dependent degradation domain (ODD) that target it for recognition by the von Hippel Lindau (VHL) complex and subsequent proteasomal degradation under aerobic condition”
BackgroundThe tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180
Vascular Endothelial Growth Factor Is a Secreted Angiogenic Mitogen
Leung, D. W., Cachianes, G., Kuang, W.-J., Goeddel, D. V., & Ferrara, N. (1989) · Science · doi:10.1126/science.2479986 · Cited by 4,986
Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients
Locatelli, F., Fishbane, S., Block, G. A., & Macdougall, I. C. (2017) · American Journal of Nephrology · doi:10.1159/000455166 · Cited by 4,813
HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O 2 Sensing
Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J. M., Lane, W. S., & Kaelin Jr., W. G. (2001) · Science · doi:10.1126/science.1059817 · Cited by 4,735
Exploiting tumour hypoxia in cancer treatment
Brown, J. M., & Wilson, W. R. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1367 · Cited by 2,828 · cited 1×
“Origins of hypoxia in solid tumours The presence of hypoxia in tumours is a well-established source of resistance to radiation therapy and chemotherap”
Background
Cited by
Items 501–600 of 999
RBPs Play Important Roles in Vascular Endothelial Dysfunction Under Diabetic Conditions
Yang, C., Kelaini, S., Caines, R., & Margariti, A. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.01310 · Cited by 29
Zhou, C., Zou, Q., Jiang, Y.-Z., & Zheng, J. J. (2020) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00528.2019 · Cited by 34
Oxygen Sensing: A Common Crossroad in Cancer and Neurodegeneration
Quaegebeur, A., & Carmeliet, P. (2010) · Current topics in microbiology and immunology · doi:10.1007/82_2010_83 · Cited by 33
Tumour thermotolerance, a physiological phenomenon involving vessel normalisation
Dings, R. P. M., Loren, M. L., Zhang, Y., Mikkelson, S., Mayo, K. H., Corry, P. M., & Griffin, R. J. (2011) · International Journal of Hyperthermia · doi:10.3109/02656736.2010.510495 · Cited by 31
Sumii, Y., Kotoku, N., Fukuda, A., Kawachi, T., Sumii, Y., Arai, M., & Kobayashi, M. (2015) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2015.01.021 · Cited by 28
Goswami, K. K., Sarkar, M., Ghosh, S., Saha, A., Ghosh, T., Guha, I., Barik, S., Banerjee, S., Roy, S., Bose, A., et al. (2016) · Molecular Immunology · doi:10.1016/j.molimm.2016.10.008 · Cited by 31
Du, J., Wang, X., Dong, X., Zhang, C., Mei, L., Zang, Y., Yan, L., Zhang, H., & Gu, Z. (2019) · Nanoscale · doi:10.1039/c8nr09618j · Cited by 28
Oxidative stress and therapeutic opportunities: focus on the Ewing’s sarcoma family of tumors
Smith, D. G., Magwere, T., & Burchill, S. A. (2011) · Expert Review of Anticancer Therapy · doi:10.1586/era.10.224 · Cited by 30
Jing, S., Wang, Y. D., Chen, L.-Q., Sang, M., Zheng, M., Sun, G. G., Qianyun, L. I. U., Cheng, Y. J., & Yang, C.-R. (2012) · Diseases of the Esophagus · doi:10.1111/j.1442-2050.2011.01321.x · Cited by 31
Bousquet, P. A., Sandvik, J. A., Arntzen, M. Ø., Edin, N. F. J., Mikalsen, S. G., Krengel, U., Pettersen, E. O., & Thiede, B. (2015) · International Journal of Proteomics · doi:10.1155/2015/678527 · Cited by 35
Cancer cell aggregate hypoxia visualized in vitro via biocompatible fiber sensors
Xue, R., Nelson, M. T., Teixeira, S. A., Viapiano, M. S., & Lannutti, J. J. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.10.055 · Cited by 29
Image-Guided Radiotherapy Targets Macromolecules through Altering the Tumor Microenvironment
Appelbe, O. K., Zhang, Q., Pelizzari, C. A., Weichselbaum, R. R., & Kron, S. J. (2016) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.6b00465 · Cited by 29
Sabatini, P. V., Speckmann, T., Nian, C., Glavas, M. M., Wong, C. K., Yoon, J. S., Kin, T., Shapiro, A. M. J., Gibson, W. T., Verchere, C. B., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2017.12.033 · Cited by 29
Differential anti-tumour effects of MTH1 inhibitors in patient-derived 3D colorectal cancer cultures
van der Waals, L. M., Laoukili, J., Jongen, J. M. J., Raats, D., Rinkes, I. H. M. B., & Kranenburg, O. (2019) · Scientific Reports · doi:10.1038/s41598-018-37316-w · Cited by 29
Molecular principles of tissue invasion and metastasis
Dhanisha, S. S., & Guruvayoorappan, C. (2023) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00348.2022 · Cited by 31
Optimization of Tumor Radiotherapy With Modulators of Cell Metabolism: Toward Clinical Applications
Danhier, P., Saedeleer, C. J. D., Karroum, O., Preter, G. D., Porporato, P. E., Jordan, B. F., Gallez, B., & Sonveaux, P. (2013) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2013.05.008 · Cited by 28
Mönnich, D., Troost, E. G. C., Kaanders, J. H. A. M., Oyen, W. J. G., Alber, M. L., & Thorwarth, D. (2012) · Physics in Medicine and Biology · doi:10.1088/0031-9155/57/6/1675 · Cited by 29
GBM radiosensitizers: dead in the water…or just the beginning?
Bindra, R. S., Chalmers, A. J., Evans, S. M., & Dewhirst, M. W. (2017) · Journal of Neuro-Oncology · doi:10.1007/s11060-017-2427-7 · Cited by 30
Self-citationHong, B., Lui, V. W. Y., Hui, E. P., Ng, M. H. L., Cheng, S.-H., Sung, F. L., Tsang, C., Tsao, S., & Chan, A. T. �. (2009) · Investigational New Drugs · doi:10.1007/s10637-009-9356-z · Cited by 27
Pachymic Acid Sensitizes Gastric Cancer Cells to Radiation Therapy by UpregulatingBaxthrough Hypoxia
Lu, C., Cai, D., & Ma, J. (2018) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x18500465 · Cited by 26
A comprehensive overview on the molecular biology of human glioma: what the clinician needs to know
López, P. D. D., Saiz-López, P., Gargini, R., Sola-Vendrell, E., & Tejada, S. (2020) · Clinical & Translational Oncology · doi:10.1007/s12094-020-02340-8 · Cited by 27
Dewhirst, M. W., Oleson, J. R., Kirkpatrick, J. P., & Secomb, T. W. (2022) · Cancers · doi:10.3390/cancers14071701 · Cited by 30
Self-citationZhou, R., Zhao, D., Beeraka, N. M., Wang, X., Lu, P., Song, R., Chen, K., & Liu, J. (2022) · Metabolites · doi:10.3390/metabo12100943 · Cited by 32
Barišić, S., Schmidt, C., Walczak, H., & Kulms, D. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.04.028 · Cited by 28
Yeom, C. J., Zeng, L., Zhu, Y., Hiraoka, M., & Harada, H. (2011) · Cancers · doi:10.3390/cancers3033610 · Cited by 27
Krupar, R., Hautmann, M., Pathak, R. R., Varier, I. V., McLaren, C., Gaag, D., Hellerbrand, C., Evert, M., Laban, S. A., Idel, C., et al. (2017) · American Journal Of Pathology · doi:10.1016/j.ajpath.2017.09.013 · Cited by 27
Recent Research on Methods to Improve Tumor Hypoxia Environment
Zhu, X., Du, J., Zhu, D. Y., Ren, S., Chen, K., & Zhu, H. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/5721258 · Cited by 30
Kranjc, S., Tevž, G., Kamenšek, U., Vidic, S., Čemažar, M., & Serša, G. (2009) · Radiation Research · doi:10.1667/rr1873.1 · Cited by 26
Multi-Modality Imaging of a Murine Mammary Window Chamber for Breast Cancer Research
Schafer, R., Leung, H. M., & Gmitro, A. F. (2014) · BioTechniques · doi:10.2144/000114191 · Cited by 25
Meng, L., Gan, S., Zhou, Y., Cheng, Y., Ding, Y., Tong, X., Wu, J., Hu, Y., & Yuan, A. (2018) · Biomaterials Science · doi:10.1039/c8bm00753e · Cited by 26
Zebrafish Xenografts Unveil Sensitivity to Olaparib beyond BRCA Status
Varanda, A. B., Martins-Logrado, A., Ferreira, M. G., & Fior, R. (2020) · Cancers · doi:10.3390/cancers12071769 · Cited by 28
Chen, H., Sun, T., Zeng, W., Zeng, X., Mei, L., Jiang, C., & Zhao, Y. (2021) · ACS Materials Letters · doi:10.1021/acsmaterialslett.1c00677 · Cited by 25
Validation of photoacoustic/ultrasound dual imaging in evaluating blood oxygen saturation
Liu, S., Zhang, R., Han, T., Pan, Y., Zhang, G., Long, X., Zhao, C., Wang, M., Li, X., Yang, F., et al. (2022) · Biomedical Optics Express · doi:10.1364/boe.469747 · Cited by 27
Diameter of tumor blood vessels is a good parameter to estimate HIF-1-active regions in solid tumors
Harada, H., Xie, X., Itasaka, S., Zeng, L., Zhu, Y., Morinibu, A., Shinomiya, K., & Hiraoka, M. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.06.062 · Cited by 25
Choi, Y. J., Heo, K., Park, H. S., Yang, K., & Jeong, M. H. (2016) · International Journal of Oncology · doi:10.3892/ijo.2016.3647 · Cited by 25
He, Q., Hu, H., Zhang, Q., Wu, T., Zhang, Y., Li, K., & Shi, C. (2020) · Chemical Engineering Journal · doi:10.1016/j.cej.2020.125478 · Cited by 25
Oral Glutamine Reduces Radiation Morbidity in Breast Conservation Surgery
Rubio, I., Suva, L. J., Todorova, V., Bhattacharyya, S., Kaufmann, Y., Maners, A., Smith, M., & Klimberg, V. S. (2013) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607112474994 · Cited by 25
Wadsworth, B. J., Cederberg, R. A., Lee, C.-M., Firmino, N. S., Franks, S. E., Pan, J., Colpo, N., Lin, K., Bénard, F., & Bennewith, K. L. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.07.015 · Cited by 27
Iessi, E., Vona, R., Cittadini, C., & Matarrese, P. (2021) · Biomedicines · doi:10.3390/biomedicines9121942 · Cited by 30
Zeman, E. M., Schreiber, E. C., & Tepper, J. E. (2020) · Elsevier eBooks · doi:10.1016/b978-0-323-47674-4.00027-x · Cited by 45
Baskar, R., Yap, S. P., Chua, K. L. M., & Itahana, K. (2012) · Europe PMC (PubMed Central) · Cited by 48
Kotoku, N., Fujioka, S., Nakata, C., Yamada, M., Sumii, Y., Kawachi, T., Arai, M., & Kobayashi, M. (2011) · Tetrahedron · doi:10.1016/j.tet.2011.05.009 · Cited by 24
Exploiting the tumor microenvironment for theranostic imaging
Stasinopoulos, I. A., Penet, M., Chen, Z., Kakkad, S. M., Glunde, K., & Bhujwalla, Z. M. (2011) · NMR in Biomedicine · doi:10.1002/nbm.1664 · Cited by 30
Proceedings of the National Cancer Institute Workshop on Charged Particle Radiobiology
Mohan, R., Held, K. D., Story, M. D., Grosshans, D. R., & Capala, J. (2017) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2017.12.260 · Cited by 26
Ligand-induced perturbation of the HIF-2α:ARNT dimer dynamics
Motta, S., Minici, C., Corrada, D., Bonati, L., & Pandini, A. (2018) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1006021 · Cited by 25
Buckley, A. M., Dunne, M. R., Lynam‐Lennon, N., Kennedy, S. A., Cannon, A., Reynolds, A., Maher, S. G., Reynolds, J. V., Kennedy, B. N., & O'Sullivan, J. N. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.01.009 · Cited by 24
Hypoxia-Directed Drug Strategies to Target the Tumor Microenvironment
Hay, M. P., Hicks, K. O., & Wang, J. (2013) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-5915-6_6 · Cited by 26
Bradshaw, T., Yip, S. S. F., Jallow, N., Forrest, L. J., & Jeraj, R. (2014) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2014.02.016 · Cited by 25
Cycling hypoxia selects for constitutive HIF stabilization
Pressley, M., Gallaher, J. A., Brown, J. S., Tomaszewski, M. R., Borad, P., Damaghi, M., Gillies, R. J., & Whelan, C. J. (2021) · Scientific Reports · doi:10.1038/s41598-021-85184-8 · Cited by 24
Birindelli, G., Drobnjaković, M., Morath, V., Steiger, K., D’Alessandria, C., Gourni, E., Afshar‐Oromieh, A., Weber, W., Rominger, A., Eiber, M., et al. (2021) · Cancers · doi:10.3390/cancers13143429 · Cited by 24
“In tumors, hypoxia occurs in regions with low vascular density [53].”
Fontanella, A. N., Schroeder, T., Hochman, D. W., Chen, R. E., Hanna, G., Haglund, M. M., Secomb, T. W., Palmer, G. M., & Dewhirst, M. W. (2013) · Microcirculation · doi:10.1111/micc.12072 · Cited by 25
Self-citationCombined therapies of antithrombotics and antioxidants delayin silicobrain tumour progression
Martínez‐González, A., Durán‐Prado, M., Calvo, G. F., Alcain, F. J., Pérez-Romasanta, L. A., & Pérez‐García, V. M. (2014) · Mathematical Medicine and Biology A Journal of the IMA · doi:10.1093/imammb/dqu002 · Cited by 24
Normoxic regulation of HIF-1α in prostate cancer
Ranasinghe, W. K. B., Baldwin, G. S., Shulkes, A., Bolton, D. M., & Patel, O. (2014) · Nature Reviews Urology · doi:10.1038/nrurol.2013.110-c2 · Cited by 22
Silver-Nanoparticle-Mediated Therapies in the Treatment of Pancreatic Cancer
Foulkes, R., Asgari, M. A., Curtis, A. D. M., & Hoskins, C. (2019) · ACS Applied Nano Materials · doi:10.1021/acsanm.9b00439 · Cited by 23
Kudo, T., Ueda, M., Konishi, H., Kawashima, H., Kuge, Y., Mukai, T., Miyano, A., Tanaka, S., Kizaka‐Kondoh, S., Hiraoka, M., et al. (2010) · Molecular Imaging and Biology · doi:10.1007/s11307-010-0418-6 · Cited by 25
Hsp90 inhibitor NVP-AUY922 enhances radiation sensitivity of tumor cell lines under hypoxia
Djuzenova, C. S., Blassl, C., Roloff, K., Kuger, S., Katzer, A., Niewidok, N., Günther, N., Polat, B., Sukhorukov, V. L., & Flentje, M. P. (2012) · Cancer Biology & Therapy · doi:10.4161/cbt.19294 · Cited by 26
Peng, C., Liu, G., Huang, K., Zheng, Q., Li, Y., & Yu, C. (2018) · Molecular Therapy — Oncolytics · doi:10.1016/j.omto.2018.11.004 · Cited by 23
Stabilisation and Knockdown of HIF - Two Distinct Ways Comparably Important in Radiotherapy
Ströfer, M., JELKMANN, W. E. B., Metzen, E., Brockmeier, U., Dunst, J., & Depping, R. (2011) · Cellular Physiology and Biochemistry · doi:10.1159/000335794 · Cited by 24
Tumor-Associated Carbonic Anhydrases IX and XII
Ondriskova, E., Debreova, M., & Pastoreková, S. (2015) · Elsevier eBooks · doi:10.1016/b978-0-444-63258-6.00010-x · Cited by 23
Searching for the Metabolic Signature of Cancer: A Review from Warburg’s Time to Now
Jacquet, P., & Stéphanou, A. (2022) · Biomolecules · doi:10.3390/biom12101412 · Cited by 31
Honey dilution impact on in vitro wound healing: Normoxic and hypoxic condition
Chaudhary, A., Bag, S., Barui, A., Banerjee, P., & Chatterjee, J. (2015) · Wound Repair and Regeneration · doi:10.1111/wrr.12297 · Cited by 22
Blood oxygen level‐dependent liver MRI: Can It predict microvascular invasion in HCC?
Jhaveri, K. S., Cleary, S. P., Fischer, S. E., Haider, M. A., Pargoankar, V., Khalidi, K., Moshonov, H., & Gallinger, S. (2012) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.23858 · Cited by 22
Hypoxia‐inducible factors – regulation, role and comparative aspects in tumourigenesis
Hansen, A. E., Kristensen, A. T., Law, I. G., Jørgensen, J. T., & Engelholm, S. A. (2010) · Veterinary and Comparative Oncology · doi:10.1111/j.1476-5829.2010.00233.x · Cited by 28
Roossink, F., de Jong, S., Wisman, G. B. A., van der Zee, A. G. J., & Schuuring, E. M. D. (2012) · Cellular Oncology · doi:10.1007/s13402-012-0091-7 · Cited by 22
[Hypoxia in cancer malignity. Review].
Arvelo, F. A., & Cotte, C. (2009) · PubMed · Cited by 34
Malamas, A. S., Jin, E., Gujrati, M. D., & Lu, Z. (2016) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.6b00227 · Cited by 23
Hypoxia and hydrogen sulfide differentially affect normal and tumor-derived vascular endothelium
Bianco, S., Mancardi, D., Merlino, A., Bussolati, B., & Munaron, L. (2017) · Redox Biology · doi:10.1016/j.redox.2017.03.015 · Cited by 22
Kawachi, T., Tanaka, S., Fukuda, A., Sumii, Y., Setiawan, A., Kotoku, N., Kobayashi, M., & Arai, M. (2019) · Marine Drugs · doi:10.3390/md17030163 · Cited by 23
Single Acquisition Quantitative Single‐Point Electron Paramagnetic Resonance Imaging
Jang, H., Subramanian, S., Devasahayam, N., Saito, K., Matsumoto, S., Krishna, M. C., & McMillan, A. B. (2013) · Magnetic Resonance in Medicine · doi:10.1002/mrm.24886 · Cited by 22
Jackson, I. L., Zhang, X., Hadley, C. C., Rabbani, Z. N., Zhang, Y., Marks, S., & Vujašković, Ž. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.04.014 · Cited by 24
Curtis, K. K., Wong, W. W., & Ross, H. J. (2016) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2016.05.005 · Cited by 26
Chitneni, S. K., Bida, G. T., Zalutsky, M. R., & Dewhirst, M. W. (2014) · Journal of Nuclear Medicine · doi:10.2967/jnumed.114.137448 · Cited by 21
Self-citationKostrikov, S., Johnsen, K. B., Braunstein, T. H., Gudbergsson, J. M., Fliedner, F. P., Obara, E. A. A., Hamerlik, P., Hansen, A. E., Kjær, A., Hempel, C., et al. (2021) · Communications Biology · doi:10.1038/s42003-021-02275-y · Cited by 22
Sun, T., Zhang, X., Hou, C., Yu, S., Zhang, Y., Yu, Z., Kong, L., Liu, C., Feng, L., Wang, D., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.941219 · Cited by 32
Ushijima, H., Suzuki, Y., Oike, T., Komachi, M., Yoshimoto, Y., Ando, K., Okonogi, N., Sato, H., Noda, S., Saito, J.-I., et al. (2015) · Journal of Radiation Research · doi:10.1093/jrr/rrv021 · Cited by 22
Preparation of artificial red cell and its application on alleviation of tumor hypoxia
Qu, J., Guo, X., Li, W., Hou, W., Zhang, H., Luo, L., Zhu, C., Yang, J., Yin, X., Yuan, T., et al. (2017) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2017.09.039 · Cited by 22
Luo, T., Gao, J., Lin, N., & Wang, J. (2020) · Nanomaterials · doi:10.3390/nano10101951 · Cited by 23
Hypoxia-Responsive Luminescent CEST MRI Agent for In Vitro and In Vivo Tumor Detection and Imaging
Karan, S., Cho, M. Y., Lee, H., Park, H. S., Han, E. H., Song, Y., Lee, Y., Kim, M., Cho, J., Sessler, J. L., et al. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c01745 · Cited by 21
“10 The efficacy of chemotherapeutics can also be reduced by tumor hypoxia.”
Usefulness of HIF-1 Imaging for Determining Optimal Timing of Combining Bevacizumab and Radiotherapy
Ou, G., Itasaka, S., Zeng, L., Shibuya, K., Yi, J., Harada, H., & Hiraoka, M. (2009) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2009.02.083 · Cited by 22
Jung, D., Lee, H., Jeong, S., Lee, H., Lee, E., Kim, Y. C., Ahn, K. S., Chen, C., & Kim, S. (2011) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.34.850 · Cited by 22
Sumii, Y., Kotoku, N., Fukuda, A., Kawachi, T., Arai, M., & Kobayashi, M. (2015) · Marine Drugs · doi:10.3390/md13127074 · Cited by 21
Tumors exposed to acute cyclic hypoxia show increased vessel density and delayed blood supply
Gaustad, J.-V., Simonsen, T. G., Roa, A. M. A., & Rofstad, E. K. (2013) · Microvascular Research · doi:10.1016/j.mvr.2012.11.002 · Cited by 20
Dose painting based on tumor uptake of Cu-ATSM and FDG: a comparative study
Clausen, M. M., Hansen, A. E., Lundemann, M. J., Hollensen, C., Pommer, T., af Rosenschöld, P. M., Kristensen, A. T., Kjær, A., McEvoy, F. J., & Engelholm, S. A. (2014) · Radiation Oncology · doi:10.1186/s13014-014-0228-0 · Cited by 20
Models and discovery strategies for new therapies of retinoblastoma
Houston, S. K. S., Lampidis, T. J., & Murray, T. G. (2013) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2013.772975 · Cited by 21
Mu, H., Ge, Y. P., Li, H., Wang, M., Cui, Y., Zhang, T., Song, T., & Liu, C. (2021) · Cellular Oncology · doi:10.1007/s13402-021-00625-w · Cited by 24
Ademi, H., Shinde, D. A., Gassmann, M., Gerst, D., Chaachouay, H., Vogel, J., & Gorr, T. A. (2021) · PLoS ONE · doi:10.1371/journal.pone.0251765 · Cited by 23
Vascular damage in tumors: a key player in stereotactic radiation therapy?
Kozin, S. V. (2022) · Trends in cancer · doi:10.1016/j.trecan.2022.06.002 · Cited by 21
Huang, X., & Zhang, W. (2023) · Small Methods · doi:10.1002/smtd.202301326 · Cited by 22
Organic coordination nanoparticles for phototheranostics
Ren, H., Li, J., Lovell, J. F., & Zhang, Y. (2024) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2023.215634 · Cited by 20
Luminescent Probe Based Techniques for Hypoxia Imaging
Jaworski, J. W. (2017) · Journal of Nanomedicine Research · doi:10.15406/jnmr.2017.06.00160 · Cited by 21
Integrated omics profiling identifies hypoxia-regulated genes in HCT116 colon cancer cells
Chen, J.-T., Liu, C.-C., Yu, J., Li, H., & Lai, M. (2018) · Journal of Proteomics · doi:10.1016/j.jprot.2018.02.031 · Cited by 22
Zhu, C., Martin, H. L., Crouch, B. T., Martinez, A. F., Li, M., Palmer, G. M., Dewhirst, M. W., & Ramanujam, N. (2018) · Biomedical Optics Express · doi:10.1364/boe.9.003399 · Cited by 19
Self-citationSynergy of hypoxia relief and chromatin remodeling to overcome tumor radiation resistance
Zhang, Z., Wang, L., Ding, Y., Wu, J., Hu, Y., & Yuan, A. (2020) · Biomaterials Science · doi:10.1039/d0bm00119h · Cited by 20
Villa, C., Chaplain, M. A. J., & Lorenzi, T. (2020) · Vietnam Journal of Mathematics · doi:10.1007/s10013-020-00445-9 · Cited by 24
Metabolic Reprogramming, Questioning, and Implications for Cancer
Jacquet, P., & Stéphanou, A. (2021) · Biology · doi:10.3390/biology10020129 · Cited by 25
Ertle, C. M., Rommel, F. R., Tumala, S., Moriwaki, Y., Klein, J., Kruse, J., Gieler, U., & Peters, E. M. J. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.631881 · Cited by 21
Tsukamoto, S., Yamashita, S., Kim, Y. H., Kumazoe, M., Huang, Y., Yamada, K., & Tachibana, H. (2012) · FEBS Letters · doi:10.1016/j.febslet.2012.07.065 · Cited by 20
Vessel network formation in response to intermittent hypoxia is frequency dependent
Ehsan, S. M., & George, S. C. (2015) · Journal of Bioscience and Bioengineering · doi:10.1016/j.jbiosc.2015.01.017 · Cited by 19
Miki, S., Imamichi, S., Fujimori, H., Tomiyama, A., Fujimoto, K., Satomi, K., Matsushita, Y., Matsuzaki, S., Takahashi, M., Ishikawa, E., et al. (2018) · Cancer Science · doi:10.1111/cas.13637 · Cited by 20
Zhao, W., Hou, M., Wang, J., Song, D., & Niu, Y. (2024) · BMC Medical Imaging · doi:10.1186/s12880-024-01548-2 · Cited by 22
“On the one hand, the rapid proliferation of cancer cells leads to relative hypoxia in the peritumoral area [44], resulting in the production of numerous hypoxia-related factors such as hypoxia-inducible factor-1 (HIF-1).”
Metadata
- Authors
- Dewhirst, M. W., Cao, Y., & Moeller, B.
- Affiliations
- Duke Medical Center (US)
- Corresponding author
- Dewhirst, Mark W.
- Venue
- Nature Reviews Cancer
- Published
- 2008-06
- Volume
- 8
- Issue
- 6
- Pages
- 425-437
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- PMC
- PMC3943205
- OpenAlex
- W2016861891
- Cited by
- 1,022
- References
- 161
- Citations by year
- 2026: 27 · 2025: 29 · 2024: 30 · 2023: 52 · 2022: 60 · 2021: 70 · 2020: 76 · 2019: 44 · 2018: 64 · 2017: 53 · 2016: 73 · 2015: 65 · 2014: 63 · 2013: 63 · 2012: 62
- FWCI
- 4.55
- Type
- journal article
- Language
- en
- Update notices
- erratum (2008-07-03)
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (CA40355, R01CA040355, P50CA068438)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Kruppel-like factors research
- Keywords
- tumor hypoxia, free radicals, reactive oxygen species, reactive nitrogen species, HIF-1, tumor angiogenesis, radiotherapy response, tumor heterogeneity, immune cell infiltration, tumor cell survival, endothelial cells
- MeSH terms
- Animals, Free Radicals, Humans, Neoplasms, Neovascularization, Pathologic, Nitric Oxide, Oxygen, Cell Hypoxia, Vascular Endothelial Growth Factor A, Hypoxia-Inducible Factor 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.